Receiver operating characteristic (ROC) curve analysis of the tumour markers CEA, CA 50 and CA 242 in pancreatic cancer; results from a prospective study.

類似資料

• Clinical evaluation of a new serum tumour marker CA 242 in pancreatic carcinoma.
  著者:: Pasanen, P. A., 等
  出版事項: (1992)
• A prospective study of serum tumour markers carcinoembryonic antigen, carbohydrate antigens 50 and 242, tissue polypeptide antigen and tissue polypeptide specific antigen in the diagnosis of pancreatic cancer with special reference to multivariate diagnostic score.
  著者:: Pasanen, P. A., 等
  出版事項: (1994)
• CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA.
  著者:: Haglund, C., 等
  出版事項: (1994)
• Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases.
  著者:: Kuusela, P., 等
  出版事項: (1991)
• Receiver Operating Characteristics (ROC) Curve Area Analysis Using the ROC ANALYZER
  著者:: Centor, Robert M., 等
  出版事項: (1989)